Covid-19: Africa scrambles to increase genomic testing capacity as variants spread

Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency are not represented in clinical trials for heart failure. Moreover, many of the recommended medications can cause haemolysis this group patients. We present case a 71-year-old woman G6PD admitted acute non-ischemic failure reduced ejection fraction. Our experience showed that combination ethacrynic acid and spironolactone is safe effective relief volume overload Studies needed to determine whether morbidity mortality benefits established regimens extend patients deficiency.